Physician profile
Jean Mullen
NPI 1174622914
$290.46
in general payments reported to CMS, 2019-2025
13 companies · $40.13 in 2025
The $40.13 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.64 · 2022: $52.78 · 2023: $29.03 · 2024: $117 · 2025: $40.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $186.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $45.74 | 2022-2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Cranial Technologies, INC | $40.13 | 2025 | Doc Band |
| Verrica Pharmaceuticals INC. | $35.06 | 2024 | Ycanth |
| Sanofi Pasteur INC. | $23.85 | 2021 | |
| Kaleo, INC. | $21.78 | 2022 | |
| Sanofi-Aventis U.S. LLC | $18.00 | 2024 | |
| Supernus Pharmaceuticals, INC. | $17.70 | 2024 | Qelbree |
| Astrazeneca Pharmaceuticals LP | $16.78 | 2024 | Flumist Quadrivalent |
| Pierre Fabre Pharmaceuticals, INC. | $14.84 | 2022 | |
| Ironshore Pharmaceuticals INC. | $14.70 | 2023 | Jornay Pm |
| Seqirus USA INC | $14.09 | 2024 | Flucelvax |
| Takeda Pharmaceuticals U.S.A., INC. | $13.91 | 2021 | |
| Corium, LLC | $13.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Mullen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.